News Features Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019 Todd Neale December 10, 2019
News Conference News AHA 2019 Dapagliflozin Has Benefits Across Heart Failure Subgroups Todd Neale November 17, 2019
News Daily News Decline in US Deaths From CVD and Diabetes Is Leveling Off Todd Neale August 27, 2019
News Conference News EAS 2019 Bempedoic Acid/Ezetimibe Combo Lowers LDL Cholesterol in High-Risk Patients Michael O'Riordan May 30, 2019
News Daily News EXCEL Insights: CABG Outcomes for Left Main CAD Have Improved Substantially Michael O'Riordan April 22, 2019
News Conference News ACC 2019 New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin Shelley Wood March 26, 2019
News Daily News Similar MACCE in Coronary Patients With Diabetes and CKD Treated With CABG or PCI L.A. McKeown January 31, 2019